Magnetic targeting and ultrasound mediated drug delivery: Benefits, limitations and combination

References

• Langer R. Drug delivery and targeting. Nature 1998; 392(6679 Suppl.)5–10
   PubMed Web of Science ®Google Scholar
• Harrison C. The patent cliff steepens. Nature Reviews Drug Discovery 2011; 10(1)12–3
   PubMed Web of Science ®Google Scholar
• Arruebo M. Drug delivery from structured porous inorganic materials. Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology 2011; 4(1)16–30
   PubMed Web of Science ®Google Scholar
• Pankhurst QA, Connolly J, Jones SK, Dobson J. Applications of magnetic nanoparticles in biomedicine. Journal of Physics D: Applied Physics 2003; 36(13)R167–R81
   Web of Science ®Google Scholar
• Jackson JK, Pirmoradi FN, Wan CPL, Siu T, Chiao M, Burt HM. Increased accumulation of paclitaxel and doxorubicin in proliferating capillary cells and prostate cancer cells following ultrasound exposure. Ultrasonics 2011; 51(8)932–9
   PubMed Web of Science ®Google Scholar
• Schlicher RK, Radhakrishna H, Tolentino TP, Apkarian RP, Zarnitsyn V, Prausnitz MR. Mechanism of intracellular delivery by acoustic cavitation. Ultrasound Med Biol 2006; 32(6)915–24
   PubMed Web of Science ®Google Scholar
• Arruebo M, Fernández-Pacheco R, Ibarra MR, Santamaría J. Magnetic nanoparticles for drug delivery. Nano Today 2007; 2(3)22–32
   Web of Science ®Google Scholar
• Lubbe AS, Alexiou C, Bergemann C. Clinical applications of magnetic drug targeting. Journal of Surgical Research Feb, 2001; 95(2)200–6
   PubMed Web of Science ®Google Scholar
• Lubbe AS, Bergemann C, Riess H, Schriever F, Reichardt P, Possinger K, et al. Clinical experiences with magnetic drag targeting: A phase I study with 4′-epidoxorubicin in 14 patients with advanced solid tumors. Cancer Research 1996; 56(20)4686–93
   PubMed Web of Science ®Google Scholar
• Forbes SJ, Hodgson HJF. Review article: Gene therapy in gastroenterology and hepatology. Alimentary Pharmacology and Therapeutics 1997; 11(5)823–36
   PubMed Web of Science ®Google Scholar
• Verma IM, Somia N. Gene therapy – Promises, problems and prospects. Nature 1997; 389(6648)239–42
   PubMed Web of Science ®Google Scholar
• Sun C, Lee JSH, Zhang M. Magnetic nanoparticles in MR imaging and drug delivery. Advanced Drug Delivery Reviews 2008; 60(11)1252–65
   PubMed Web of Science ®Google Scholar
• McBain SC, Yiu HHP, Dobson J. Magnetic nanoparticles for gene and drug delivery. International Journal of Nanomedicine 2008; 3(2)169–80
   PubMed Web of Science ®Google Scholar
• Plank C, Zelphati O, Mykhaylyk O. Magnetically enhanced nucleic acid delivery. Ten years of magnetofection-Progress and prospects. Advanced Drug Delivery Reviews 2011; 63(14-15)1300–31
   PubMed Web of Science ®Google Scholar
• Deckers R, Rome C, Moonen CTW. The role of ultrasound and magnetic resonance in local drug delivery. Journal of Magnetic Resonance Imaging 2008; 27(2)400–9
   PubMed Web of Science ®Google Scholar
• Ferrara K, Pollard R, Borden M. Ultrasound microbubble contrast agents: Fundamentals and application to gene and drug delivery. Annual Reviews in Biomedical Engineering 2007; 9: 415–47
   PubMed Web of Science ®Google Scholar
• Xenariou S, Griesenbach U, Liang HD, Zhu J, Farley R, Somerton L, et al. Use of ultrasound to enhance nonviral lung gene transfer in vivo. Gene Therapy 2007; 14(9)768–74
   PubMed Web of Science ®Google Scholar
• Tachibana K, Uchida T, Ogawa K, Yamashita N, Tamura K. Induction of cell-membrane porosity by ultrasound. Lancet 1999; 353(9162)1409
   PubMed Web of Science ®Google Scholar
• Freeman MW, Arrott A, Watson JHL. Magnetism in medicine. Journal of Applied Physics 1960; 31(5)S404–S5
   Web of Science ®Google Scholar
• Polyak B, Friedman G. Magnetic targeting for site-specific drug delivery: Applications and clinical potential. Expert Opinion on Drug Delivery 2009; 6(1)53–70
   PubMed Web of Science ®Google Scholar
• Andrä W, Nowak H. Magnetism in Medicine: A Handbook2nd. Wiley-VCH, Weinheim 2007
   Google Scholar
• Durán JDG, Arias JL, Gallardo V, Delgado AV. Magnetic colloids as drug vehicles. Journal of Pharmaceutical Sciences 2008; 97(8)2948–83
   PubMed Web of Science ®Google Scholar
• Barry SE. Challenges in the development of magnetic particles for therapeutic applications. International Journal of Hyperthermia 2008; 24(6)451–66
   PubMed Web of Science ®Google Scholar
• Thiesen B, Jordan A. Clinical applications of magnetic nanoparticles for hyperthermia. International Journal of Hyperthermia 2008; 24(6)467–74
   PubMed Web of Science ®Google Scholar
• Kami D, Takeda S, Itakura Y, Gojo S, Watanabe M, Toyoda M. Application of magnetic nanoparticles to gene delivery. International Journal of Molecular Sciences 2011; 12(6)3705–22
   PubMed Web of Science ®Google Scholar
• Willard MA, Kurihara LK, Carpenter EE, Calvin S, Harris VG. Chemically prepared magnetic nanoparticles. International Materials Reviews 2004; 49(3-4)125–70
   Web of Science ®Google Scholar
• Hans ML, Lowman AM. Biodegradable nanoparticles for drug delivery and targeting. Current Opinion in Solid State and Materials Science 2002; 6(4)319–27
   Web of Science ®Google Scholar
• Neuberger T, Schöpf B, Hofmann H, Hofmann M, Von Rechenberg B. Superparamagnetic nanoparticles for biomedical applications: Possibilities and limitations of a new drug delivery system. Journal of Magnetism and Magnetic Materials 2005; 293(1)483–96
   Web of Science ®Google Scholar
• Meyers PH, Cronic F, Nice CM, Jr. Experimental approach in the use and magnetic control of metallic iron. The American Journal of Roentgenology, Radium Therapy, and Nuclear 1963; 90: 1068–77
   PubMed Web of Science ®Google Scholar
• Medeiros SF, Santos AM, Fessi H, Elaissari A. Stimuli-responsive magnetic particles for biomedical applications. International Journal of Pharmaceutics 2011; 403(1–2)139–61
   PubMed Web of Science ®Google Scholar
• Zimmerman U, Scheurich P, Pilwat G, Benz R. Cells with manipulated functions: New perspectives for cell biology, medicine, and technology. Angewandte Chemie – International Edition in English 1981; 20(4)325–44
   Web of Science ®Google Scholar
• Senyei A, Widder K, Czerlinski G. Magnetic guidance of drug-carrying microspheres. Journal of Applied Physics 1978; 49(6)3578–83
   Web of Science ®Google Scholar
• Senyei AE, Reich SD, Gonczy C, Widder KJ. In vivo kinetics of magnetically targeted low-dose doxorubicin. Journal of Pharmaceutical Sciences 1981; 70(4)389–91
   PubMed Web of Science ®Google Scholar
• Widder KJ, Morris RM, Poore GA, Howard DP, Senyei AE. Selective targeting of magnetic albumin microspheres containing low-dose doxorubicin – total remission in Yoida Srcoma-bearing rats. European Journal of Cancer & Clinical Oncology. [Article] 1983; 19(1)135–9
   PubMedGoogle Scholar
• Edelman ER, Brown L, Taylor J, Langer R. In vitro and in vivo kinetics of regulated drug release from polymer matrices by oscillating magnetic fields. Journal of Biomedical Materials Research 1987; 21(3)339–53
   PubMed Web of Science ®Google Scholar
• Hafeli UO, Sweeney SM, Beresford BA, Sim EH, Macklis RM. Magnetically directed poly(lactic acid) 90Y-microspheres: Novel agents for targeted intracavitary radiotherapy. Journal of Biomedical Materials Research 1994; 28(8)901–8
   PubMed Web of Science ®Google Scholar
• Hafeli UO, Sweeney SM, Beresford BA, Humm JL, Macklis RM. Effective targeting of magnetic radioactive 90Y-microspheres to tumor cells by an externally applied magnetic field. Preliminary in vitro and in vivo results. Nuclear Medicine and Biology 1995; 22(2)147–55
   PubMed Web of Science ®Google Scholar
• Lübbe AS, Bergemann C, Huhnt W, Fricke T, Riess H, Brock JW, et al. Preclinical experiences with magnetic drug targeting: Tolerance and efficacy. Cancer Research 1996; 56(20)4694–701
   PubMed Web of Science ®Google Scholar
• Alexiou C, Arnold W, Klein RJ, Parak FG, Hulin P, Bergemann C, et al. Locoregional cancer treatment with magnetic drug targeting. Cancer Research 2000; 60(23)6641–8
   PubMed Web of Science ®Google Scholar
• Koda J, Venook A, Walser E, Goodwin S. A multicenter, phase I/II trial of hepatic intra-arterial delivery of doxorubicin hydrochloride adsorbed to Magnetic Targeted Carriers in patients with hepatocellular carcinoma. Eur J Cancer. [Meeting Abstract] 2002; 38: S18
   PubMed Web of Science ®Google Scholar
• Dykxhoorn DM, Lieberman J. Running interference: Prospects and obstacles to using small interfering RNAs as small molecule drugs. Annual Review of Biomedical Engineering 2006; 8: 377–402
   PubMed Web of Science ®Google Scholar
• Mykhaylyk O, Vlaskou D, Tresilwised N, Pithayanukul P, Möller W, Plank C. Magnetic nanoparticle formulations for DNA and siRNA delivery. Journal of Magnetism and Magnetic Materials 2007; 311(1 SPEC. ISS.)275–81
   Web of Science ®Google Scholar
• Mah C, Fraites TJ, Jr, Zolotukhin I, Song S, Flotte TR, Dobson J, et al. Improved method of recombinant AAV2 delivery for systemic targeted gene therapy. Molecular Therapy 2002; 6(1)106–12
   PubMed Web of Science ®Google Scholar
• Hughes C, Galea-Lauri J, Farzaneh F, Darling D. Streptavidin paramagnetic particles provide a choice of three affinity-based capture and magnetic concentration strategies for retroviral vectors. Molecular Therapy 2001; 3(4)623–30
   PubMed Web of Science ®Google Scholar
• Scherer F, Anton M, Schillinger U, Henke J, Bergemann C, Krüger A, et al. Magnetofection: Enhancing and targeting gene delivery by magnetic force in vitro and in vivo. Gene Therapy 2002; 9(2)102–9
   PubMed Web of Science ®Google Scholar
• Abdallah B, Hassan A, Benoist C, Goula D, Behr JP, Demeneix BA. A powerful nonviral vector for in vivo gene transfer into the adult mammalian brain: Polyethylenimine. Human Gene Therapy 1996; 7(16)1947–54
   PubMed Web of Science ®Google Scholar
• Plank C, Schillinger U, Scherer F, Bergemann C, Rémy JS, Krötz F, et al. The magnetofection method: Using magnetic force to enhance gene delivery. Biological Chemistry 2003; 384(5)737–47
   PubMed Web of Science ®Google Scholar
• Cai D, Mataraza JM, Qin ZH, Huang Z, Huang J, Chiles TC, et al. Highly efficient molecular delivery into mammalian cells using carbon nanotube spearing. Nature Methods 2005; 2(6)449–54
   PubMed Web of Science ®Google Scholar
• Bonetta L. The inside scoop – Evaluating gene delivery methods. Nature Methods 2005; 2(11)875–82
   Web of Science ®Google Scholar
• Kamau SW, Hassa PO, Steitz B, Petri-Fink A, Hofmann H, Hofmann-Amtenbrink M, et al. Enhancement of the efficiency of non-viral gene delivery by application of pulsed magnetic field. Nucleic Acids Research 2006; 34(5)e.40
   Web of Science ®Google Scholar
• Ng KY, Liu Y. Therapeutic ultrasound: Its application in drug delivery. Medicinal Research Reviews 2002; 22(2)204–23
   PubMed Web of Science ®Google Scholar
• Newman CM, Lawrie A, Brisken AF, Cumberland DC. Ultrasound gene therapy: On the road from concept to reality. Echocardiography 2001; 18(4)339–47
   PubMed Web of Science ®Google Scholar
• Yuh EL, Shulman SG, Mehta SA, Xie J, Chen L, Frenkel V, et al. Delivery of systemic chemotherapeutic agent to tumors by using focused ultrasound: Study in a murine model. Radiology 2005; 234(2)431–7
   PubMed Web of Science ®Google Scholar
• Azhari H. Basics of Biomedical ultrasound for engineers1st. John Wiley and sons, Inc., New Jersey 2010
   Google Scholar
• Ferrara KW. Driving delivery vehicles with ultrasound. Advanced Drug Delivery Reviews 2008; 60(10)1097–102
   PubMed Web of Science ®Google Scholar
• Bailey MR, Khokhlova VA, Sapozhnikov OA, Kargl SG, Crum LA. Physical mechanisms of the therapeutic effect of ultrasound (a review). Acoustical Physics 2003; 49(4)369–88
   Web of Science ®Google Scholar
• Apfel RE. Sonic effervescence: A tutorial on acoustic cavitation. Journal of the Acoustical Society of America 1997; 101(3)1227–37
   Web of Science ®Google Scholar
• Iwanaga K, Tominaga K, Yamamoto K, Habu M, Maeda H, Akifusa S, et al. Local delivery system of cytotoxic agents to tumors by focused sonoporation. Cancer Gene Therapy 2007; 14(4)354–63
   PubMed Web of Science ®Google Scholar
• Meairs S, Alonso A. Ultrasound, microbubbles and the blood-brain barrier. Progress in Biophysics and Molecular Biology 2007; 93(1-3)354–62
   PubMed Web of Science ®Google Scholar
• Nyborg WL. Ultrasonic microstreaming and related phenomena. British Journal of Cancer 1982; 45(Suppl. 5)156–60
   Google Scholar
• Marmottant P, Hilgenfeldt S. Controlled vesicle deformation and lysis by single oscillating bubbles. Nature 2003; 423(6936)153–6
   PubMed Web of Science ®Google Scholar
• O'Neill BE, Li KCP. Augmentation of targeted delivery with pulsed high intensity focused ultrasound. International Journal of Hyperthermia 2008; 24(6)506–20
   PubMed Web of Science ®Google Scholar
• Meltzer RS, Tickner EG, Sahines TP, Popp RL. The source of ultrasound contrast effect. Journal of Clinical Ultrasound 1980; 8(2)121–7
   PubMed Web of Science ®Google Scholar
• Harvey CJ, Pilcher JM, Eckersley RJ, Blomley MJK, Cosgrove DO. Advances in ultrasound. Clinical Radiology 2002; 57(3)157–77
   PubMedGoogle Scholar
• Nanda NC. History of echocardiographic contrast agents. Clinical Cardiology 1997; 20(10 SUPPL.)I7–I11
   PubMed Web of Science ®Google Scholar
• Klibanov AL. Ligand-carrying gas-filled microbubbles: Ultrasound contrast agents for targeted molecular imaging. Bioconjugate Chem. [Article] 2005; 16(1)9–17
   PubMed Web of Science ®Google Scholar
• Quaia E. Contrast Media in Ultrasonography: Basic principles and clinical applications. Berlin: Springer-Verlag. 2005
   Google Scholar
• Unger EC, Hersh E, Vannan M, McCreery T. Gene delivery using ultrasound contrast agents. Echocardiography 2001; 18(4)355–61
   PubMed Web of Science ®Google Scholar
• Unger EC, McCreery TP, Sweitzer RH, Caldwell VE, Wu YQ. Acoustically active lipospheres containing paclitaxel – A new therapeutic ultrasound contrast agent. Investigative Radiology 1998; 33(12)886–92
   PubMed Web of Science ®Google Scholar
• Tachibana K, Tachibana S. Albumin microbubble echo-contrast material as an enhancer for ultrasound accelerated thrombolysis. Circulation 1995; 92(5)1148–50
   PubMed Web of Science ®Google Scholar
• Lindner JR, Kaul S. Delivery of drugs with ultrasound. Echocardiography 2001; 18(4)329–37
   PubMed Web of Science ®Google Scholar
• Wu Y, Unger EC, McCreery TP, Sweitzer RH, Shen D, Wu G, et al. Binding and lysing of blood clots using MRX-408. Investigative Radiology 1998; 33(12)880–5
   PubMed Web of Science ®Google Scholar
• Prentice P, Cuschierp A, Dholakia K, Prausnitz M, Campbell P. Membrane disruption by optically controlled microbubble cavitation. Nature Physics 2005; 1(2)107–10
   Web of Science ®Google Scholar
• Guzmán HR, Nguyen DX, Khan S, Prausnitz MR. Ultrasound-mediated disruption of cell membranes. I. Quantification of molecular uptake and cell viability. Journal of the Acoustical Society of America 2001; 110(1)588–96
   PubMed Web of Science ®Google Scholar
• Guzmán HR, Nguyen DX, Khan S, Prausnitz MR. Ultrasound-mediated disruption of cell membranes. II. Heterogeneous effects on cells. Journal of the Acoustical Society of America 2001; 110(1)597–606
   PubMed Web of Science ®Google Scholar
• Price RJ, Skyba DM, Kaul S, Skalak TC. Delivery of colloidal particles and red blood cells to tissue through microvessel ruptures created by targeted microbubble destruction with ultrasound. Circulation 1998; 98(13)1264–7
   PubMed Web of Science ®Google Scholar
• Lentacker I, Geers B, Demeester J, De Smedt SC, Sanders NN. Design and evaluation of doxorubicin-containing microbubbles for ultrasound-triggered doxorubicin delivery: Cytotoxicity and mechanisms involved. Molecular Therapy 2010; 18(1)101–8
   PubMed Web of Science ®Google Scholar
• Lindner JR, Coggins MP, Kaul S, Klibanov AL, Brandenburger GH, Ley K. Microbubble persistence in the microcirculation during ischemia/reperfusion and inflammation is caused by integrin- and complement- mediated adherence to activated leukocytes. Circulation 2000; 101(6)668–75
   PubMed Web of Science ®Google Scholar
• Villanueva FS, Jankowski RJ, Klibanov S, Pina ML, Alber SM, Watkins SC, et al. Microbubbles targeted to intercellular adhesion molecule-1 bind to activated coronary artery endothelial cells. Circulation 1998; 98(1)1–5
   PubMed Web of Science ®Google Scholar
• Lum AFH, Borden MA, Dayton PA, Kruse DE, Simon SI, Ferrara KW. Ultrasound radiation force enables targeted deposition of model drug carriers loaded on microbubbles. Journal of Controlled Release 2006; 111(1–2)128–34
   PubMed Web of Science ®Google Scholar
• Kim HJ, Greenleaf JF, Kinnick RR, Bronk JT, Bolander ME. Ultrasound-mediated transfection of mammalian cells. Human Gene Therapy 1996; 7(11)1339–46
   PubMed Web of Science ®Google Scholar
• Greenleaf WJ, Bolander ME, Sarkar G, Goldring MB, Greenleaf JF. Artificial cavitation nuclei significantly enhance acoustically induced cell transfection. Ultrasound in Medicine and Biology 1998; 24(4)587–95
   PubMed Web of Science ®Google Scholar
• Lawrie A, Brisken AF, Francis SE, Cumberland DC, Crossman DC, Newman CM. Microbubble-enhanced ultrasound for vascular gene delivery. Gene Therapy 2000; 7(23)2023–7
   PubMed Web of Science ®Google Scholar
• Li T, Tachibana K, Kuroki M. Gene Transfer with Echo-enhanced Contrast Agents: Comparison between Albunex, Optison, and Levovist in Mice – Initial Results. Radiology 2003; 229(2)423–8
   PubMed Web of Science ®Google Scholar
• Rahim A, Taylor SL, Bush NL, ter Haar GR, Bamber JC, Porter CD. Physical parameters affecting ultrasound/microbubble-mediated gene delivery efficiency in vitro. Ultrasound in Medicine and Biology 2006; 32(8)1269–79
   PubMed Web of Science ®Google Scholar
• Unger EC, Hersh E, Vannan M, Matsunaga TO, McCreery T. Local drug and gene delivery through microbubbles. Progress in Cardiovascular Diseases 2001; 44(1)45–54
   PubMed Web of Science ®Google Scholar
• Shohet RV, Chen S, Zhou YT, Wang Z, Meidell RS, Unger RH, et al. Echocardiographic destruction of albumin microbubbles directs gene delivery to the myocardium. Circulation 2000; 101(22)2554–6
   PubMed Web of Science ®Google Scholar
• Tsunoda S, Mazda O, Oda Y, Iida Y, Akabame S, Kishida T, et al. Sonoporation using microbubble BR14 promotes pDNA/siRNA transduction to murine heart. Biochemical and Biophysical Research Communications 2005; 336(1)118–27
   PubMed Web of Science ®Google Scholar
• Kodama T, Aoi A, Watanabe Y, Horie S, Kodama M, Li L, et al. Evaluation of transfection efficiency in skeletal muscle using nano/microbubbles and ultrasound. Ultrasound Med Biol 2010; 36(7)1196–205
   PubMed Web of Science ®Google Scholar
• Geers B, Lentacker I, Sanders NN, Demeester J, Meairs S, De Smedt SC. Self-assembled liposome-loaded microbubbles: The missing link for safe and efficient ultrasound triggered drug-delivery. Journal of Controlled Release 2011; 152(2)249–56
   PubMed Web of Science ®Google Scholar
• Cochran MC, Eisenbrey J, Ouma RO, Soulen M, Wheatley MA. Doxorubicin and paclitaxel loaded microbubbles for ultrasound triggered drug delivery. International Journal of Pharmaceutics 2011; 414(1–2)161–70
   PubMed Web of Science ®Google Scholar
• Thanh NTK, Magnetic Nanoparticles: From Fabrication to Clinical Applications. CRC Press, Taylor and Francis Group, Boca Raton 2011
   Google Scholar
• Hynynen K. MRIgHIFU: A tool for image-guided therapeutics. Journal of Magnetic Resonance Imaging 2011; 34(3)482–93
   PubMed Web of Science ®Google Scholar
• D'Arrigo JS, Method for the production of medical-grade lipid-coated microbubbles, paramagnetic labeling of such microbubbles and therapeutic uses of microbubbles. US Patent US5215680. 1993
   Google Scholar
• Smith MJ, Ho VHB, Darton NJ, Slater NKH. Effect of Magnetite Nanoparticle Agglomerates on Ultrasound Induced Inertial Cavitation. Ultrasound Med Biol 2009; 35(6)1010–4
   PubMed Web of Science ®Google Scholar
• Saravanan M, Bhaskar K, Maharajan G, Pillai KS. Ultrasonically controlled release and targeted delivery of diclofenac sodium via gelatin magnetic microspheres. International Journal of Pharmaceutics 2004; 283(1–2)71–82
   PubMed Web of Science ®Google Scholar
• Kaminski MD, Xie Y, Mertz CJ, Finck MR, Chen H, Rosengart AJ. Encapsulation and release of plasminogen activator from biodegradable magnetic microcarriers. European Journal of Pharmaceutical Sciences 2008; 35(1–2)96–103
   PubMed Web of Science ®Google Scholar
• Wong KK, Huang I, Kim YR, Tang H, Yang ES, Kwong KK, et al. In vivo study of microbubbles as an MR susceptibility contrast agent. MagnResonMed 2004; 52(3)445–52
   Google Scholar
• Yang F, Li L, Li Y, Chen Z, Wu J, Gu N. Superparamagnetic nanoparticle-inclusion microbubbles for ultrasound contrast agents. Physics in Medicine and Biology 2008; 53(21)6129–41
   PubMed Web of Science ®Google Scholar
• Yang F, Li Y, Chen Z, Zhang Y, Wu J, Gu N. Superparamagnetic iron oxide nanoparticle-embedded encapsulated microbubbles as dual contrast agents of magnetic resonance and ultrasound imaging. Biomaterials 2009; 30(23–24)3882–90
   PubMed Web of Science ®Google Scholar
• Park JI, Jagadeesan D, Williams R, Oakden W, Chung S, Stanisz GJ, et al. Microbubbles loaded with nanoparticles: A route to multiple imaging modalities. ACS Nano 2010; 4(11)6579–86
   PubMed Web of Science ®Google Scholar
• Soetanto K, Watarai H. Development of magnetic microbubbles for drug delivery system (DDS). Japanese Journal of Applied Physics, Part 1: Regular Papers and Short Notes and Review Papers 2000; 39(5 B)3230–2
   Google Scholar
• Soetanto K, Watarai H, Ferromagnetic Ultrasound Microbubbles Contrast Agent. Proceedings of the 25th Annual International Conference of the IEEE Engineering in Medicine and Biology Society. 2003;2:1226–29
   Google Scholar
• Stride E, Porter C, Prieto AG, Pankhurst Q. Enhancement of Microbubble Mediated Gene Delivery by Simultaneous Exposure to Ultrasonic and Magnetic Fields. Ultrasound in Medicine & Biology 2009; 35(5)861–8
   PubMed Web of Science ®Google Scholar
• Mulvana H, Eckersley RJ, Browning R, Hajnal JV, Stride E, Barrack T, Tang, M. Pankhurst, Q. Wells, D. editors. Enhanced gene transfection in vivo using magnetic localisation ofultrasound contrast agents: Preliminary results. Proceedings of the IEEE Ultrasonics Symposium 2010; 670-73
   Google Scholar
• Vlaskou D, Mykhaylyk O, Krötz F, Hellwig N, Renner R, Schillinger U, Gleich B, Heidsieck A, Schmitz G, Hensel K, Plank C. Magnetic and Acoustically Active Lipospheres for Magnetically Targeted Nucleic Acid Delivery. Advanced Functional Materials 2010; 20(22)3881–94
   Web of Science ®Google Scholar
• Vlaskou D, Pradhan P, Bergemann C, Klibanov AL, Hensel K, Schmitz G, Plank C, Mykhaylyk O, editors. Magnetic microbubbles: Magnetically targeted and ultrasound-triggered vectors for gene delivery in vitro. AIP Conference Proceedings 8th International conference on the scientific and clinical applications of magnetic carriers. 2010; 1311:485–94
   Google Scholar
• Allen LM, Kent T, Wolfe C, Ficco C, Johnson J. A magnetically targetable drug carrier for paclitaxel. Scientific and Clinical Applications of Magnetic Carriers, Häfeli Urs, Schütt Wolfgang, Teller Joachim, Zborowski Maciej. Plenum Press, New York 1997; 481–494
   Google Scholar